IL1B and Sepsis: Our results indicate that during the early stages of septic shock (first 24 h after ICU admission, when the blood samples were obtained) the IL1B promoter was hypo-methylated in septic shock patients compared to sepsis patients, so suggesting IL1B would be highly expressed in septic shock patients, as we recently described (3).